SIGLEC1 and metastatic malignant neoplasm in the lymph nodes: The combined results indicated that high CD169 expression was obviously related with TNM stage (III–IV vs I–II) (OR = 0.62, 95% CI: 0.48, 0.80, P < 0.001) and Lymph node metastasis (yes vs no)(OR = 0.66, 95% CI: 0.47–0.94; P = 0.020).